Estramustina [Inn-Spanish] en es it fr

Estramustina [Inn-Spanish] Brand names, Estramustina [Inn-Spanish] Analogs

Estramustina [Inn-Spanish] Brand Names Mixture

  • No information avaliable

Estramustina [Inn-Spanish] Chemical_Formula

C23H31Cl2NO3

Estramustina [Inn-Spanish] RX_link

http://www.rxlist.com/cgi/generic2/estramustine.htm

Estramustina [Inn-Spanish] fda sheet

Estramustina_[Inn-Spanish] FDA

Estramustina [Inn-Spanish] msds (material safety sheet)

Estramustina [Inn-Spanish] Synthesis Reference

No information avaliable

Estramustina [Inn-Spanish] Molecular Weight

440.403 g/mol

Estramustina [Inn-Spanish] Melting Point

104.5 oC

Estramustina [Inn-Spanish] H2O Solubility

No information avaliable

Estramustina [Inn-Spanish] State

Solid

Estramustina [Inn-Spanish] LogP

4.636

Estramustina [Inn-Spanish] Dosage Forms

Capsule

Estramustina [Inn-Spanish] Indication

For the palliative treatment of patients with metastatic and/or progressive carcinoma of the prostate

Estramustina [Inn-Spanish] Pharmacology

Estramustine is an antineoplastic agent indicated in the palliative treatment of patients with metastatic and/or progressive carcinoma of the prostate. Estramustine is a combination of estradiol with nornitrogen mustard. The precise mechanism of action of estramustine is unknown. Unlike other alkylating agents, estramustine does not directly damage DNA.

Estramustina [Inn-Spanish] Absorption

No information avaliable

Estramustina [Inn-Spanish] side effects and Toxicity

No information avaliable

Estramustina [Inn-Spanish] Patient Information

No information avaliable

Estramustina [Inn-Spanish] Organisms Affected

Humans and other mammals